Literature DB >> 576531

Decreased parathyroid function in hyperthyroidism: interrelationships between serum parathyroid hormone, calcium-phosphorus metabolism and thyroid function.

L Mosekilde, M S Christensen.   

Abstract

Serum immunoreactive parathyroid hormone (S-iPTH) was measured together with serum and urinary calcium and phosphorus in 45 hyperthyroid patients in order to assess parathyroid fe of hyperthyroidism. The prevalence of hypercalcaemia was 51.1% using serum calcium values corrected for individual variations in serum albumin concentration compared to 15.6% using the uncorrected calcium values. S-iPTH was decreased and inversely correlated to serum calcium values. S-iPTH was decreased and inversely correlated to serum calcium (corrected). Subnormal levels of S-iPTH were found in 28.9% of the patients. The urinary excretion of calcium and phosphorus was increased and positively correlated to the degree of hyperthyroidism. The tubular reabsorption of calcium (TRCa%) was decreased, positively correlated to S-iPTH and inversely correlated to serum calcium. Increased mobilisation of bone mineral in hyperthyroidism is suggested mainly to be responsible for the elevated serarathyroid function.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 576531     DOI: 10.1530/acta.0.0840566

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  10 in total

1.  Hyperparathyroidism associated with hyperthyroidism.

Authors:  M Terzolo; A Piovesan; G Osella; P Caraci; F Orlandi; A Angeli
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

Review 2.  Calcium metabolism in thyroid disease.

Authors:  G Benker; N Breuer; R Windeck; D Reinwein
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

3.  Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis.

Authors:  N Kojima; S Sakata; S Nakamura; K Nagai; H Takuno; T Ogawa; I Matsui; H Sarui; K Miura
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

4.  Effect of thyrotoxicosis and its treatment on mineral and bone metabolism.

Authors:  J D Lalau; J L Sebert; A Marie; A Fournier; J Quichaud
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

5.  Enhanced suppression of 1,25(OH)2D3 and intact parathyroid hormone in Graves' disease as compared to toxic nodular goiter.

Authors:  H Czernobilsky; S Scharla; H Schmidt-Gayk; R Ziegler
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

6.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials.

Authors:  Jørn Ditzel; Hans Henrik Lervang
Journal:  Diabetes Metab Syndr Obes       Date:  2009-10-08       Impact factor: 3.168

7.  Thyroid disorders and bone mineral metabolism.

Authors:  Dinesh Kumar Dhanwal
Journal:  Indian J Endocrinol Metab       Date:  2011-07

8.  Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis.

Authors:  Donghee Kwak; Jane Ha; Yousun Won; Yeongkeun Kwon; Sungsoo Park
Journal:  BMJ Open       Date:  2021-05-13       Impact factor: 2.692

9.  Dyslipidemia and serum mineral profiles in patients with thyroid disorders.

Authors:  Abdelgayoum A Abdel-Gayoum
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

10.  The long-term oral administration of thyroxine: effects on blood hematological and biochemical features in broiler breeder hens.

Authors:  R Keshavarz; A Akhlaghi; M J Zamiri; M R Jafarzadeh Shirazi; F Saemi; A A Akhlaghi; M Zhandi; M Afrouziyeh; M J Zuidhof
Journal:  Poult Sci       Date:  2019-12-01       Impact factor: 3.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.